`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________________
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`WOCKHARDT BIO AG, TEVA PHARMACEUTICALS USA, INC.,
`AUROBINDO PHARMA U.S.A. INC., and SUN PHARMACEUTICAL
`INDUSTRIES, LTD., SUN PHARMA GLOBAL FZE
`and AMNEAL PHARMACEUTICALS LLC,
`Petitioners,
`
`v.
`
`ASTRAZENECA AB,
`Patent Owner.
`
`_____________________________
`
`Case IPR2015-01340
`Patent RE44,186 E1
`_____________________________
`
`
`
`JOINT NOTICE OF STIPULATION
`MODIFYING DUE DATE 4
`
`
`
`
`1 Wockhardt from IPR2016-01029, Teva from IPR2016-01122, Aurobindo from
`
`IPR2016-01117, and Sun/Amneal from IPR2016-01104 has each been joined as a
`
`Petitioner to this proceeding.
`
`
`
`As authorized in the Scheduling Order (Paper 17, 2), Petitioner Mylan (on
`
`behalf of all Petitioners) and Patent Owner AstraZeneca stipulate to the following
`
`change in Due Date 4:
`
`
`
`DUE DATE 4 — move from December 8 to December 12, 2016.
`
`Due Dates 1-3 were previously modified and are now moot. Due Date 5 was
`
`previously moved to December 19 and is not changed in this stipulation.
`
`Respectfully,
`
`
`
`/ Richard Torczon /
`Richard Torczon, Reg. No. 34,448
`Backup counsel for Mylan
`
`
`
`
`
`/ Anthony A. Hartmann /
`Anthony A. Hartmann, Reg. No. 43,662
`Counsel for Patent Owner AstraZeneca AB
`
`
`
`
`
`
`Date: 30 November 2016
`
`
`
`
`
`
`
`Date: 30 November 2016
`
`
`
`
`
`
`
`
`
`-1-
`
`
`
`CERTIFICATE OF SERVICE
`37 CFR §42.6(e)(i)
`
`
`I certify that, on 30 November 2016, this JOINT NOTICE OF
`
`STIPULATION MODIFYING DUE DATE 4 was served on AstraZeneca at the
`
`following electronic service addresses:
`
`
`
`Charles E. Lipsey
`
`charles.lipsey@finnegan.com
`
`Eric E. Grondahl
`
`egrondahl@mccarter.com
`
`John D. Livingstone
`
`john.livingstone@finnegan.com
`
`Anthony A. Hartmann
`
`anthony.hartmann@finnegan.com
`
`M. David Weingarten
`
`david.weingarten@finnegan.com
`
`Nicole A. Conlon
`
`nicole.conlon@finnegan.com
`
`Daniel M. Silver
`
`dsilver@mccarter.com
`
`Kassandra M. Officer
`
`kassandra.officer@finnegan.com
`
`on Wockhardt at the following service electronic addresses:
`
`Frederick R. Ball
`
`FRBall@duanemorris.com
`
`Patrick C. Gallagher
`
`PCGallagher@duanemorris.com
`
`on Teva at the following service electronic addresses:
`
`Iain A. McIntyre
`
`IMcIntyre@carlsoncaspers.com
`
`Gary J. Speier
`
`GSpeier@carlsoncaspers.com
`
`-2-
`
`
`
`on Aurobindo at the following service electronic addresses:
`
`Sailesh K. Patel
`
`SPatel@schiffhardin.com
`
`Joel Wallace
`
`JWallace@schiffhardin.com
`
`George Yu
`
`GYu@schiffhardin.com
`
`
`and on Sun/Amneal at the following service electronic addresses:
`
`Samuel S. Park
`
`spark@winston.com
`
`Andrew R. Sommer
`
`asommer@winston.com
`
`
`
`Dated: 30 November 2016
`
`
`
`
`/ Richard Torczon /
` Richard Torczon, Reg. No. 34,448
`
`-3-